Evidence map›Paper›PMID 38636436›Full record

ArticleBioorganic chemistry2024

Improved synthesis and application of an alkyne-functionalized isoprenoid analogue to study the prenylomes of motor neurons, astrocytes and their stem cell progenitors.

Kiall F Suazo, Vartika Mishra, Sanjay Maity, Shelby A Auger, Katarzyna Justyna, Alexandru M Petre, Linda Ottoboni, Jessica Ongaro, Stefania P Corti, Francesco Lotti and 2 more

Abstract read
In one paragraph

Article in Bioorganic chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. ACS chemical biology · 2025
    Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Kiall F SuazoDepartment of Chemistry, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: suazo003@umn.edu.
Vartika MishraCenter for Motor Neuron Biology and Diseases, Department of Neurology. Columbia University Irving Medical Center. New York, NY 10032, USA; Department of Pathology & Cell Biology. Columbia University Irving Medical Center. New York, NY 10032, USA. Electronic address: vartikarmishra@gmail.com.
Sanjay MaityDepartment of Chemistry, University of Minnesota, Minneapolis, MN 55455, USA.
Shelby A AugerDepartment of Chemistry, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: auger054@umn.edu.
Katarzyna JustynaDepartment of Chemistry, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: kjustyna@umn.edu.
Alexandru M PetreDepartment of Chemistry, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: petre096@umn.edu.
Linda OttoboniDepartment of Pathophysiology and Transplantation, Dino Ferrari Center, Università degli Studi di Milano, Milan, Italy. Electronic address: linda.ottoboni@unimi.it.
Jessica OngaroNeurology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Stefania P CortiDepartment of Pathophysiology and Transplantation, Dino Ferrari Center, Università degli Studi di Milano, Milan, Italy; Neurology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Neuromuscular and Rare Diseases Unit, Department of Neuroscience, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: stefania.corti@unimi.it.
Francesco LottiCenter for Motor Neuron Biology and Diseases, Department of Neurology. Columbia University Irving Medical Center. New York, NY 10032, USA; Department of Pathology & Cell Biology. Columbia University Irving Medical Center. New York, NY 10032, USA. Electronic address: fl2219@cumc.columbia.edu.
Serge PrzedborskiCenter for Motor Neuron Biology and Diseases, Department of Neurology. Columbia University Irving Medical Center. New York, NY 10032, USA; Department of Pathology & Cell Biology. Columbia University Irving Medical Center. New York, NY 10032, USA; Department of Neuroscience, Pathology, and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032, USA. Electronic address: sp30@cumc.columbia.edu.
Mark D DistefanoDepartment of Chemistry, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: diste001@umn.edu.

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Timothy C. Hallstrom · 1998 to 2026
$100.4M
Training Grant: Functional Proteomics of AgingT32AG029796 · NIA · UNIVERSITY OF MINNESOTA · PI EDGAR A ARRIAGA, Douglas G Mashek · 2008 to 2026
$6.6M
Protein prenylation inhibition for the treatment of tauopathiesR01NS107442 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PRZEDBORSKI, SERGE E · 2018 to 2022
$3.1M
Training the Next Generation of Chemical BiologistsT32GM132029 · NIGMS · UNIVERSITY OF MINNESOTA · PI Erin Elizabeth Carlson, William Charles Krause Pomerantz · 2019 to 2026
$2.7M
Chemical Approaches for Exploring Protein Prenylation in Living CellsR35GM141853 · NIGMS · UNIVERSITY OF MINNESOTA · PI MARK D DISTEFANO · 2021 to 2026
$2.4M
SMN post-translational modification in Spinal Muscular AtrophyR21NS101575 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LOTTI, FRANCESCO · 2017 to 2018
$440k
NCI NIH HHS P30 CA077598NIA NIH HHS T32 AG029796NIGMS NIH HHS R35 GM141853NIGMS NIH HHS T32 GM132029NINDS NIH HHS R01 NS107442NINDS NIH HHS R21 NS101575
6 · The paper itself

Abstract

Protein prenylation is one example of a broad class of post-translational modifications where proteins are covalently linked to various hydrophobic moieties. To globally identify and monitor levels of all prenylated proteins in a cell simultaneously, our laboratory and others have developed chemical proteomic approaches that rely on the metabolic incorporation of isoprenoid analogues bearing bio-orthogonal functionality followed by enrichment and subsequent quantitative proteomic analysis. Here, several improvements in the synthesis of the alkyne-containing isoprenoid analogue C15AlkOPP are reported to improve synthetic efficiency. Next, metabolic labeling with C15AlkOPP was optimized to obtain useful levels of metabolic incorporation of the probe in several types of primary cells. Those conditions were then used to study the prenylomes of motor neurons (ES-MNs), astrocytes (ES-As), and their embryonic stem cell progenitors (ESCs), which allowed for the identification of 54 prenylated proteins from ESCs, 50 from ES-MNs, and 84 from ES-As, representing all types of prenylation. Bioinformatic analysis revealed specific enriched pathways, including nervous system development, chemokine signaling, Rho GTPase signaling, and adhesion. Hierarchical clustering showed that most enriched pathways in all three cell types are related to GTPase activity and vesicular transport. In contrast, STRING analysis showed significant interactions in two populations that appear to be cell type dependent. The data provided herein demonstrates that robust incorporation of C15AlkOPP can be obtained in ES-MNs and related primary cells purified via magnetic-activated cell sorting allowing the identification and quantification of numerous prenylated proteins. These results suggest that metabolic labeling with C15AlkOPP should be an effective approach for investigating the role of prenylated proteins in primary cells in both normal cells and disease pathologies, including ALS.

Indexed as

AlkynesAstrocytesMotor NeuronsProtein PrenylationAnimalsCells, CulturedMiceMolecular StructureTerpenesAlkynesTerpenesClick chemistryFarnesylationGeranylgeranylationMetabolic labelingPrenylationProteomicsSynthetic probe

Identifiers

PMID38636436
PMCPMC11653755

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.